Loading...
01/11 16:21
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture: strong financial performance in some segments like energy and automotive services, but challenges in others, such as food packaging and pharma due to restructuring and competition. The share repurchase program is positive, but lack of dividend details and risks like refinery exemptions and store closures weigh negatively. The Q&A provided no additional insights to alter sentiment significantly. Overall, the varied performance across segments and lack of decisive positive or negative news suggests a neutral stock price movement.
NAV (Net Asset Value) Increased by $567 million year-over-year. The increase was driven by CVI, net of refining hedges, which contributed $547 million, and the funds excluding refining hedges were up approximately 5%. The outperformance was attributed to the continued conflict in Ukraine, increased crack spreads, and the resolution of small refinery exemptions from 2019 to 2024, which removed a $488 million liability from the CBI balance sheet.
Energy Segment EBITDA Consolidated EBITDA was $625 million for Q3 2025, compared to a loss of $35 million in Q3 2024. The improvement was due to better performance in the energy segment.
Automotive Service Revenues Increased by $11 million year-over-year in Q3 2025. Same-store sales performance contributed $21 million or a 6% increase compared to the prior year quarter. The improvement was attributed to fine-tuning product, pricing, labor, and distribution strategies.
Real Estate Adjusted EBITDA Decreased by $12 million year-over-year in Q3 2025. The decline was primarily due to the sale of the Country Club earlier in the year.
Food Packaging Adjusted EBITDA Decreased by $8 million year-over-year in Q3 2025. The decline was attributed to lower volume, higher manufacturing inefficiencies, and disruptive headwinds from the restructuring plan.
Home Fashions Adjusted EBITDA Decreased by $4 million year-over-year in Q3 2025. The decline was due to softening demand in the U.S. retail and hospitality business.
Pharma Adjusted EBITDA Decreased by $7 million year-over-year in Q3 2025. The decline was due to reduced sales resulting from generic competition in the anti-obesity market.
Liquidity As of quarter end, the holding company had cash and investments in the funds of $3.4 billion, and subsidiaries had cash and revolver availability of $1.2 billion. This liquidity is maintained to capitalize on opportunities within and outside existing operating segments.
Pharma Development: Developmental drug for PAH named TRANSCEND trial finalized. Trial to consist of 90 global sites with 300 patients. First patient dosing in Q1 2026. Potentially first disease-modifying product for PAH treatment.
Energy Segment: Energy segment consolidated EBITDA increased to $625 million in Q3 2025 from a loss of $35 million in Q3 2024.
Automotive Segment: Automotive service revenues increased by $11 million in Q3 2025 compared to prior year. Same-store sales revenue increased by $21 million or 6%. Significant changes in store footprint with 89 closures and 14 new openings in the last 12 months.
Real Estate: Real Estate Q3 2025 adjusted EBITDA decreased by $12 million due to the sale of a Country Club earlier this year. However, construction ramp-up expected to increase EBITDA in the second half of 2026.
Operational Adjustments in Automotive: Transferred majority of owned properties from Automotive to Real Estate segment to unlock value. Fine-tuning product, pricing, labor, and distribution strategies for enhanced profitability.
Food Packaging Restructuring: Adjusted EBITDA decreased by $8 million in Q3 2025 due to lower volume and restructuring headwinds. Restructuring plan expected to complete by Q2 2026.
Activism Strategy: Focus on activism strategy leveraging Icahn brand and history in proxy contests. Ability to tender for entire businesses due to balance sheet, liquidity, and permanent capital structure.
Small Refinery Exemptions: The company's reliance on small refinery exemptions granted by the EPA poses a risk. If these exemptions are not granted in the future, it could negatively impact financial performance.
Automotive Segment Store Closures: The closure of 89 underperforming stores in the automotive segment indicates operational challenges. This could lead to reduced revenue and potential restructuring costs.
Food Packaging Segment Restructuring: The ongoing restructuring plan in the food packaging segment has led to lower volumes, higher manufacturing inefficiencies, and disruptive headwinds. These issues are expected to persist until Q2 2026.
Home Fashions Demand Decline: Softening demand in the U.S. retail and hospitality business has negatively impacted the home fashions segment, leading to decreased EBITDA.
Pharma Segment Generic Competition: The pharma segment faces reduced sales due to generic competition in the anti-obesity market, which has negatively impacted EBITDA.
Real Estate Segment EBITDA Decline: The real estate segment experienced a decrease in adjusted EBITDA due to the sale of a country club, which may impact future revenue generation.
Small Refinery Exemptions: The company hopes that the Trump administration and the EPA will continue to grant small refineries the exemptions they deserve. They believe Wynnewood is entitled to receive 100% exemptions going forward.
Southwest Gas (SWX) Growth: SWX has a potential significant pipeline expansion for data center, power generation, and industrial users in Northern Nevada. Analysts predict SWX could grow net income at a 14% CAGR between 2025 and 2029, outpacing peers.
EchoStar Investment: The company sees considerable upside in EchoStar due to its highly valuable spectrum assets. Recent deals with AT&T and SpaceX have highlighted this value, with the stock increasing significantly.
IFF (International Flavors & Fragrances): IFF is near an inflection point that will enable it to close its discount to peers. The company is focusing on high-growth, innovation-led businesses, streamlining its portfolio, and restoring financial flexibility to invest in R&D and return cash to shareholders.
Caesars Entertainment: Despite recent performance disappointments, the company sees significant free cash flow being used to repurchase shares, a growing high-quality digital business, and the early stages of an iCasino rollout across the country.
Monroe Investment: The company has made a recent investment in Monroe, which operates approximately 1,100 auto service locations across the U.S. They view Monroe as an attractive investment opportunity.
Real Estate Segment: EBITDA is expected to increase in the second half of 2026 as construction ramps up at the existing club and surrounding development.
Food Packaging Restructuring: The restructuring plan is expected to impact results until its completion, now anticipated during Q2 2026.
Pharma Segment - PAH Drug Development: The company is developing a drug for PAH, with the trial named TRANSCEND. The trial will consist of approximately 90 sites globally, with total enrollment of 300 patients. The first patient is expected to be dosed in Q1 2026. If approved, it could be the first disease-modifying product for PAH treatment.
Dividend Program: No specific mention of a dividend program was made during the call.
Share Repurchase Program: The call mentioned significant free cash flow being used to repurchase shares, particularly in relation to Caesars.
The earnings call presents a mixed picture: strong financial performance in some segments like energy and automotive services, but challenges in others, such as food packaging and pharma due to restructuring and competition. The share repurchase program is positive, but lack of dividend details and risks like refinery exemptions and store closures weigh negatively. The Q&A provided no additional insights to alter sentiment significantly. Overall, the varied performance across segments and lack of decisive positive or negative news suggests a neutral stock price movement.
The earnings call presents a mixed picture. Positive aspects include strong digital business growth and share repurchases. However, challenges such as significant RINs liability, energy segment EBITDA decline, and ongoing inefficiencies in the food packaging segment offset these positives. The Q&A did not reveal additional concerns but did not alleviate existing uncertainties. Given these mixed signals, the stock price is likely to remain stable, resulting in a neutral sentiment.
The earnings call reveals several negative factors: significant declines in EBITDA across segments, a substantial EPS miss, and challenges in automotive and energy sectors. Despite cash reserves and maintained distributions, the absence of clear guidance on store closures and net asset value updates adds uncertainty. Share repurchases may offer some support, but the overall financial performance and lack of clarity in Q&A suggest a negative sentiment, likely leading to a stock price drop of 2% to 8%.
The earnings call reveals significant challenges, including negative EBITDA in the Energy segment, declining sales in the Automotive segment, and reduced EBITDA across various sectors. Despite maintaining liquidity and distribution, unclear management responses in the Q&A and ongoing investment risks suggest short-term challenges. The lack of positive catalysts or new partnerships, alongside market volatility, contributes to a negative outlook.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
